Free Trial

Stock Analyst Downgrades

Explore the most recent stock downgrades, analyst downgrades, and changes to stock analyst ratings in this continuously updated list of analyst recommendations. This page captures each newly issued downgrade, including adjustments to stock ratings, price targets, and analyst coverage, making it easy to follow all the latest downgrades and rating changes.

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Crescent Capital BDC, Inc. stock logo
CCAP
Crescent Capital BDC
Downgraded by $11.99
-8.3%
$16.00OutperformMarket Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 04:41 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.